Inspire Medical Systems, Inc. (INSP) FY2026 Q2 Statement of Cash Flows

Statement of Cash Flows

2026-04-01 to 2026-06-30

Swipe to see the full flow
Inspire Medical Systems, Inc. cash flow reconciliation, Apr 1, 2026 through Jun 30, 2026One connected Sankey reconciles operating, investing and financing net cash flows through a shared cash pool, from beginning cash to ending cash. Ribbons flow left to right on one dollar scale. Activity totals are dark gray; beginning and ending cash are blue. Cash basis for beginning and ending balances and net cash change: Cash, cash equivalents, and restricted cash. Intermediate calculation bars are lighter gray. Calculated remaining financing cash flows are purple; remaining operating and investing bundles are gray. Their underlying inflows and outflows are not separately identified. Net income is green for profit and red for loss. Identified asset purchases, sales and maturities are blue in either cash direction. Purple identifies capital transactions such as borrowing, repayments, share issuance and dividends. Free cash flow is a separate comparison, not an added cash flow. Read chart description and values below for full signed amounts, including zero items.Net (loss) → Net cash from operating activities: $314,000.00Stock-based compensation expense → Operating adjustments reconciliation: $31,226,000.00Deferred income tax expense → Operating adjustments reconciliation: $10,152,000.00Depreciation and amortization → Operating adjustments reconciliation: $4,597,000.00Accounts receivable → Operating adjustments reconciliation: $1,927,000.00Other non-cash expenses → Operating adjustments reconciliation: $193,000.00Operating adjustments reconciliation → Net cash from operating activities: $22,914,000.00Operating adjustments reconciliation → Accounts payable: $13,831,000.00Operating adjustments reconciliation → Inventories: $4,217,000.00Operating adjustments reconciliation → Accrued expenses and other liabilities: $3,905,000.00Operating adjustments reconciliation → Prepaid expenses and other current assets: $2,805,000.00Operating adjustments reconciliation → Accretion of investment discount: $237,000.00Operating adjustments reconciliation → Remaining operating cash flows, net (calculated): $186,000.00Proceeds from issuance of common stock from employee stock purchase plan → financing reconciliation: $2,193,000.00Proceeds from the exercise of stock options → financing reconciliation: $403,000.00financing reconciliation → Net cash from financing activities: $1,911,000.00financing reconciliation → Payment of taxes on net share settlement of equity awards: $685,000.00Proceeds from sales or maturities of investments → investing reconciliation: $37,642,000.00investing reconciliation → Net cash from investing activities: $3,548,000.00investing reconciliation → Purchases of investments: $24,934,000.00investing reconciliation → Capital expenditures: $9,160,000.00Exchange-rate effect → Cash sources and uses: $142,000.00Beginning cash: Cash, cash equivalents, and restricted cash → Cash sources and uses: $98,932,000.00Net cash from operating activities → Cash sources and uses: $23,228,000.00Net cash from financing activities → Cash sources and uses: $1,911,000.00Net cash from investing activities → Cash sources and uses: $3,548,000.00Cash sources and uses → Ending cash: Cash, cash equivalents, and restricted cash: $127,761,000.00Net (loss): $314,000.00Net (loss)+$314.00 KDepreciation and amortization: $4,597,000.00Depreciation & amortization+$4.60 MDeferred income tax expense: $10,152,000.00Deferred income taxes+$10.15 MAccretion of investment discount: -$237,000.00Investment discount & premium−$237.00 KStock-based compensation expense: $31,226,000.00Stock-based compensation+$31.23 MAccounts receivable: $1,927,000.00Receivables, net+$1.93 MInventories: -$4,217,000.00Inventories−$4.22 MPrepaid expenses and other current assets: -$2,805,000.00Prepaid & other assets−$2.81 MAccounts payable: -$13,831,000.00Accounts payable−$13.83 MAccrued expenses and other liabilities: -$3,905,000.00Accrued & other liabilities−$3.91 MOther non-cash expenses: $193,000.00Other non-cash expenses+$193.00 KRemaining operating cash flows, net (calculated): -$186,000.00Remaining operating (calculated)−$186.00 KNet cash from operating activities: $23,228,000.00Operating cash+$23.23 MOperating adjustments reconciliation: $48,095,000.00Proceeds from the exercise of stock options: $403,000.00Stock option exercises+$403.00 KShare repurchase of common stock: $0.00Payment of taxes on net share settlement of equity awards: -$685,000.00Stock-award tax withholding−$685.00 KProceeds from issuance of common stock from employee stock purchase plan: $2,193,000.00Employee stock purchase proceeds+$2.19 MNet cash from financing activities: $1,911,000.00Financing cash+$1.91 Mfinancing reconciliation: $2,596,000.00Capital expenditures: -$9,160,000.00PP&E purchases−$9.16 MProceeds from sales or maturities of investments: $37,642,000.00Investment sales & maturities+$37.64 MPurchases of investments: -$24,934,000.00AFS securities purchases−$24.93 MNet cash from investing activities: $3,548,000.00Investing cash+$3.55 Minvesting reconciliation: $37,642,000.00Cash sources and uses: $127,761,000.00Beginning cash: Cash, cash equivalents, and restricted cash: $98,932,000.00Beginning cash$98.93 MEnding cash: Cash, cash equivalents, and restricted cash: $127,761,000.00Ending cash$127.76 MExchange-rate effect: $142,000.00FX effect+$142.00 KCASH RECONCILIATIONOperatingflowsFinancingflowsInvestingflowsFree cash flow$14.07 MOperating cash − cash spent on PP&ECash flow / Net income73.97×Operating cash flow ÷ net incomeNet cash change+$28.83 MEnding cash − beginning cash
Chart details

Inspire Medical Systems, Inc. cash flow reconciliation, Apr 1, 2026 through Jun 30, 2026

Cash flows for Apr 1, 2026 through Jun 30, 2026. Cash basis: Cash, cash equivalents, and restricted cash. Beginning cash: Mar 31, 2026. Ending cash: Jun 30, 2026. Beginning and ending cash are dated balances. Positive cash flows add cash; negative cash flows reduce it.

Beginning cash on Mar 31, 2026
98,932,000 US dollars. Beginning cash: Cash, cash equivalents, and restricted cash
Operating activities
23,228,000 US dollars. Net cash provided. The remaining amount is calculated by subtracting the other displayed items from the operating total. This quarter is the year to date less the prior quarter's year to date. The prior quarter reported part of this section under different lines (Provision for estimated credit losses), so Impairment charge cannot be separated for this quarter. It may combine inflows and outflows.
Net (loss)
314,000 US dollars
Depreciation and amortization
4,597,000 US dollars
Deferred income tax expense
10,152,000 US dollars
Accretion of investment discount
negative 237,000 US dollars
Stock-based compensation expense
31,226,000 US dollars
Accounts receivable
1,927,000 US dollars
Inventories
negative 4,217,000 US dollars
Prepaid expenses and other current assets
negative 2,805,000 US dollars
Accounts payable
negative 13,831,000 US dollars
Accrued expenses and other liabilities
negative 3,905,000 US dollars
Other non-cash expenses
193,000 US dollars
Remaining operating cash flows, net (calculated)
negative 186,000 US dollars
Investing activities
3,548,000 US dollars. Net cash provided.
Capital expenditures
negative 9,160,000 US dollars
Proceeds from sales or maturities of investments
37,642,000 US dollars
Purchases of investments
negative 24,934,000 US dollars
Financing activities
1,911,000 US dollars. Net cash provided.
Proceeds from the exercise of stock options
403,000 US dollars
Share repurchase of common stock
0 US dollars
Payment of taxes on net share settlement of equity awards
negative 685,000 US dollars
Proceeds from issuance of common stock from employee stock purchase plan
2,193,000 US dollars
Operating adjustment reconciliation
48,095,000 US dollars. Intermediate calculation joining the displayed items and the calculated net remainder. It does not establish gross cash receipts or payments and is not an additional cash flow.
financing gross reconciliation
2,596,000 US dollars. Gross amount at the activity's junction before offsetting its receipts and deductions. It is not an additional cash source or use.
investing gross reconciliation
37,642,000 US dollars. Gross amount at the activity's junction before offsetting its receipts and deductions. It is not an additional cash source or use.
Exchange-rate effect
142,000 US dollars
Ending cash on Jun 30, 2026
127,761,000 US dollars. Ending cash: Cash, cash equivalents, and restricted cash
Cash sources and uses
127,761,000 US dollars. Opening cash plus net sources, equal to net uses plus ending cash.
Net cash change
28,829,000 US dollars. Ending cash minus beginning cash.
Cash flow / Net income
73.97×. Operating cash flow divided by reconciliation net income for the same period. Black from 0.90× through 1.10×; green above 1.10×; red below 0.90×. Color uses the unrounded ratio.
Operating cash flow
23,228,000 US dollars. Operating cash flow used in the free cash flow calculation.
Cash purchases of property, plant and equipment
9,160,000 US dollars. These cash purchases are already included in investing activities above.
Free cash flow
14,068,000 US dollars. A supplemental measure; finance-lease payments are excluded from this definition.

Chart connections

  • Beginning cash plus operating, investing and financing cash flows plus the exchange-rate effect equals ending cash. Negative amounts reduce cash.
  • Financing contributions meet at a reconciliation junction before connecting to the net cash total.
  • Investing contributions meet at a reconciliation junction before connecting to the net cash total.
  • Operating reconciliation adjustments are not all independent cash receipts.
  • Net income enters operating cash directly in the reconciliation. The adjustment junction contributes the remaining $22.91M after reconciling the other positive and negative adjustments. These connections depict an accounting reconciliation, not traced cash receipts.
  • Each activity has one net cash bar connected to the shared cash pool. Positive activity totals enter the pool; negative activity totals leave the pool to fund that activity's net payments. The central pool does not assign a particular funding source to a particular payment.
  • The intermediate calculation bars include both sides of the displayed activity breakdowns; they are not additional cash flows.
  • Operating cash flow minus cash purchases of property, plant and equipment equals free cash flow: 23,228,000 US dollars minus 9,160,000 US dollars equals 14,068,000 US dollars.
Inspire Medical Systems, Inc. (INSP) FY2026 Q2 Statement of Cash Flows Sankey chart
Free to share unchanged, with credit to Plicit.ai · CC BY-NC-ND 4.0Download PNG

Newsletter

Get the teardowns by email

Subscribe if you want the public-company teardowns in your inbox when they're released.

Product waitlist

Health Check and Teardown for your own company

A health check uncovers insights of your private books, not a public ticker. Join this list to get notified as soon as we go-live!